Enbrel DTC Campaign Should Restore Growth In Psoriasis Market, Amgen Says
This article was originally published in The Pink Sheet Daily
The company had been sponsoring a disease awareness program while working to bring a branded spot back on the air after an FDA warning letter targeted an initial ad.
You may also be interested in...
Center for Drug Evaluation & Research ad review division says Amgen's commercial overstates the TNF-inhibitor's effectiveness, fails to communicate the limitations of the indication and minimizes risk. Amgen pulls the commercial from its media schedule in the wake of the agency's letter.
The company calls on 3,500 dermatologists for its psoriatic arthritis indication; Amgen hopes to increase promotion to 9,000 dermatolgists.
Study everything together and a scale-up manufacturing after preliminary efficacy results, former FDA commissioners Gottlieb and McClellan and their coauthors recommend in a pair of white papers on how the US should respond to the coronavirus pandemic.